Press Release Harvey J. Berger, M.D. Joins Kojin Therapeutics as Chairman, President, and Chief Executive Officer 3 January 2024
Press Release Merck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference 3 January 2024
Press Release NOV Announces Fourth Quarter and Full Year 2023 Earnings Conference Call 3 January 2024
Press Release TDCX Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Remaining Outstanding Class A Ordinary Shares of the Company 3 January 2024
Press Release The Walt Disney Company and ValueAct Capital Enter Into Information-sharing Arrangement to Facilitate Strategic Consultation During Company’s Transformation 3 January 2024
Press Release Alzheon CEO Dr. Martin Tolar to Present ALZ-801/Valiltramiprosate Investigational Oral Alzheimer’s Treatment Program at Nobel Forum at Karolinska Institute in Stockholm, Sweden 3 January 2024
Press Release Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit 3 January 2024
Press Release Alzheon CEO Dr. Martin Tolar Awarded Eliška and Zdeněk Strmiska Award from Alzheimer’s Foundation for Significant Contribution Towards Research and Treatment of Alzheimer’s Disease, and Donated Cash Prize to INDRC Institute 3 January 2024
Press Release 2023’s Housing Market Woes Extend into 2024: Low Supply and Unaffordability 3 January 2024
